Interne link ProQR Announces First Participant Dosed in Phase 1 Study of AX-0811 and Virtual Investor and Analyst Educational Event on September 30, 2026 september 09, 2026 om 12:00 PM UTC
Interne link ProQR to Participate in Upcoming Investor Conferences in September 2026 september 02, 2026 om 12:00 PM UTC
Interne link ProQR Announces Second Quarter 2026 Operating and Financial Results augustus 13, 2026 om 11:00 AM UTC
Interne link ProQR Prices $50.0 Million Underwritten Registered Direct Offering and Concurrent Private Placement juni 25, 2026 om 10:35 AM UTC
Interne link ProQR Announces Positive Phase 1 Target Engagement Data for AX-0810, Establishing First Clinical Validation of the Axiomer RNA Editing Platform juni 25, 2026 om 10:25 AM UTC
Interne link ProQR Announces First Quarter 2026 Operating and Financial Results mei 12, 2026 om 11:00 AM UTC
Interne link ProQR Announces Multiple Upcoming Scientific Conference Presentations Highlighting the Breadth of its Axiomer™ RNA Editing Platform mei 11, 2026 om 12:00 PM UTC
Interne link ProQR Announces Annual General Meeting of Shareholders to be Held June 2, 2026 mei 04, 2026 om 12:00 PM UTC
Interne link ProQR Announces Nomination of Dr. Lykke Hinsch Gylvin to its Board of Directors april 30, 2026 om 12:00 PM UTC
Interne link ProQR Highlights Pipeline Expansion and Multiple Upcoming Clinical Catalysts at Investor and Analyst Event april 08, 2026 om 08:00 PM UTC
Interne link ProQR Announces Partnership with Ginkgo Bioworks and Formation of AI Advisory Board april 08, 2026 om 12:00 PM UTC
Interne link ProQR to Host Virtual Investor and Analyst Event Highlighting Pipeline on April 8, 2026 maart 25, 2026 om 12:00 PM UTC
Interne link ProQR Announces Year End 2025 Operating and Financial Results maart 12, 2026 om 11:00 AM UTC
Interne link ProQR Announces Webcast of Presentation at the 2026 Citizens Life Sciences Conference maart 03, 2026 om 09:30 PM UTC
Interne link ProQR Announces Encouraging AX-0810 Phase 1 Safety and PK Data, Development Candidate Selections, and 2026 Outlook januari 08, 2026 om 01:00 PM UTC
Interne link ProQR Announces that QR-010 Meets the Primary Endpoint in a Proof of Concept Study of Homozygous F508del Cystic Fibrosis Patients oktober 27, 2016 om 11:00 AM UTC
Interne link ProQR Announces Clinical Data Presentations and Investor & Analyst Event at NACFC september 27, 2016 om 11:00 AM UTC
Interne link ProQR to Present at Scientific and Investor Conferences in September september 06, 2016 om 11:00 AM UTC
Interne link ProQR Announces Results for the Second Quarter of 2016 augustus 17, 2016 om 11:00 AM UTC
Interne link ProQR Receives Fast Track Designation from FDA for QR-010 for Cystic Fibrosis juli 19, 2016 om 11:00 AM UTC
Interne link ProQR to Release Topline Data from Proof of Concept Study of QR-010 in Cystic Fibrosis Patients at NACFC juni 21, 2016 om 01:00 PM UTC
Interne link ProQR’s Drug Candidate QR-110 for Leber’s Congenital Amaurosis Type 10 Receives EMA and FDA Orphan Drug Designation juni 01, 2016 om 11:00 AM UTC
Interne link ProQR Announces Presentations at the European CF Conference and the JMP Life Science Conference juni 01, 2016 om 11:00 AM UTC